Fresenius Kabi USA, LLC recalls
Every recall we track for Fresenius Kabi USA, LLC — 94 in all, from 2012–2026 — plus the complaints and injury reports the public filed about them. 19 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Fresenius Kabi USA, LLC more than tripled in 2025 (12, up from 4 in 2024). 17% rated “stop using now”.
All FDA recall records for Fresenius Kabi USA, LLC since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 1 | 1 | 0 | 2 |
| 2018 | 0 | 0 | 2 | 1 | 3 |
| 2019 | 0 | 1 | 0 | 1 | 2 |
| 2020 | 2 | 2 | 5 | 0 | 9 |
| 2021 | 1 | 0 | 1 | 0 | 2 |
| 2022 | 1 | 2 | 4 | 0 | 7 |
| 2023 | 0 | 3 | 0 | 0 | 3 |
| 2024 | 3 | 1 | 0 | 0 | 4 |
| 2025 | 2 | 3 | 6 | 1 | 12 |
| 2026 (to date) | 3 | 5 | 7 | 10 | 25 |
Fresenius Kabi USA, LLC recalls before 2017
Recalls on record by year.
Most common reasons for Fresenius Kabi USA, LLC recalls
What to do if you have a recalled Fresenius Kabi USA, LLC product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Fresenius Kabi USA, LLC recalls
60 shown- Stop using nowDrug

Fresenius Kabi USA, LLC recalls Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA,
Fresenius Kabi recalls Tyenne (tocilizumab-aazg) injection due to glass particles found in some batches. This may cause serious injury if injected. Affected units have specific lot numbers and expiration dates.
Fresenius KabiAug 10, 2026 - Lower riskDrug

Fresenius Kabi USA, LLC recalls Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or
Fresenius Kabi recalls Morphine Sulfate Injection syringes that may be labeled incorrectly with Dilaudid instead of Morphine. This could lead to incorrect medication use. Consumers should check labels and contact the company for details.
Fresenius KabiAug 4, 2026 - Lower riskDrug
Fresenius Kabi USA, LLC recalls Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose
Fresenius Kabi recalls Glycopyrrolate injection vials with hair particles. This may cause allergic reactions or other issues. Stop using and contact your doctor.
Fresenius KabiJul 16, 2026 - UnratedDrug
Fresenius Kabi USA, LLC recalls Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC
Fresenius Kabi recalls specific batches of Epinephrine Injection due to failed impurities and degradations. Affected units may pose health risks if used improperly. Contact for details.
Fresenius KabiMay 14, 2026 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump, Model Number: LVP-0004
Fresenius Kabi recalls Ivenix LVP-0004 infusion pumps that may malfunction after drops or jarring, causing random touchscreen inputs. Affected units have specific model and serial numbers.
Fresen:ius KabiMay 6, 2026 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.
Fresenius Kabi recalls Ivenix Infusion System software version 5.10.2 due to potential false battery alarms that may shut down the pump. Affected units have specific product codes and software versions.
Fresenius KabiMay 6, 2026 - UnratedDrug
Fresenius Kabi USA, LLC recalls 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag, Rx only,
Fresenius Kabi recalls 0.9% Sodium Chloride Injection (250 mL) due to lack of sterility assurance. Affected batches have specific expiration dates and NDC numbers. Consumers should contact the manufacturer for details.
Fresenius KabiMar 11, 2026 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls The Large Volume Pump (LVP) of the Ivenix Infusion System (IIS). Model Number: LVP-0004.
Fresenius Kabi recalls LVP-0004 infusion pumps due to potential cassette loading lever breakage. Affected units may require replacement to prevent injury.
Fresenius KabiFeb 4, 2026 - Lower riskMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), LVP Software: LVP-SW-0005.
Fresenius Kabi recalls Ivenix Infusion System software version 5.10.2 and prior due to potential LVP duration programming errors in instructions. Affected units may require software update to prevent infusion errors.
Fresenius KabiNov 21, 2025 - Stop using nowMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), LVP Software LVP-SW-0005. Software for the controlled administration of fluids to
Fresenius Kabi recalls Ivenix Infusion System software versions 5.10.1 and earlier due to potential patient harm or death risks. Affected units may require software update or replacement.
Fresenius KabiNov 14, 2025 - UnratedDrug

Fresenius Kabi USA, LLC recalls Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC
Fresenius Kabi recalls Famotidine injection vials due to microbial contamination and endotoxin testing issues. Affected lots have specific NDC numbers and expiration dates.
Fresenius KabiNov 6, 2025 - Stop using nowMedical device
Fresenius Kabi USA, LLC recalls IVENIX INFUSION SYSTEM, LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Dual Y-Site (Qty
Fresenius Kabi recalls specific IVENIX infusion sets due to potential serious patient injury from incorrect assembly. Affected units include Lot FA25B03126. Contact for remedy details.
Fresenius KabiNov 3, 2025 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004.
Fresenius Kabi recalls Ivenix Large Volume Pump (LVP-0004) due to potential downstream occlusion alarms during low flow infusions with check valves added to the administration set.
Fresenius KabiNov 3, 2025 - Lower riskMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004.
Fresenius Kabi recalls Ivenix Infusion System (LVP-0004) due to potential phantom touches on touchscreen. Affected units have specific serial numbers and model.
Fresenius KabiSep 3, 2025 - Lower riskMedical device
Fresenius Kabi USA, LLC recalls LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Dual Y-Site (Qty 25). Product Code:
Fresenius Kabi recalls LVP Primary Administration Sets with potential for external cassette leaks. Affected units include specific product codes and lot numbers. Consumers should contact the manufacturer for details.
Fresenius KabiJun 24, 2025 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls IVENIX INFUSION SYSTEM LVP Blood Products Administration Set, Dual-Inlet, Low-Sorbing, Y-Site, Mesh Filter, 15 mL.
Fresenius Kabi recalls IVENIX infusion sets with a risk of blood clots if the 200-micron filter is incorrectly positioned. Affected units have model SET-0014-20 and UDI 20811505030034. Contact for return instructions.
Fresen:ius KabiMay 12, 2025 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), LVP Software LVP-SW-0005. Indicated for use in a hospital and in outpatient care
Fresenius Kabi recalls Ivenix Infusion System software version 5.9.2 and earlier due to potential pump failure during alarms or infusion switching. Affected units sold in hospitals and outpatient care.
Fresenius KabiJan 10, 2025 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump, Model Number: LVP-0004
Fresenius Kabi recalls Ivenix Infusion System Large Volume Pump Model LVP-0004 due to potential pneumatic valve failure that may stop active infusions or prevent pump use. Affected units have specific serial numbers listed in the recall.
Fresenius KabiDec 6, 2024 - Stop using nowMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004, Software Version 5.9.1 and prior. Infusion pump software for
Fresenius Kabi recalls Ivenix Infusion System software versions 5.9.1 and older due to potential alarms, pump failure, or unresponsive screens during therapy, risking serious harm or death.
Fresenius KabiAug 30, 2024 - Stop using nowMedical device
Fresenius Kabi USA, LLC recalls LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site (Qty 25), Product Code: SET-0013-25.
Fresenius Kabi recalls LVP Primary Administration Sets with Product Code SET-0013-25 due to potential medication overdose risk. Affected units may cause dose errors during IV infusion.
Fresenius KabiAug 1, 2024 - Stop using nowMedical device
Fresenius Kabi USA, LLC recalls LVP Software of the Ivenix Infusion System (IIS), Version 5.8.0.
Fresenius Kabi recalls Ivenix Infusion System software version 5.8.0 due to potential underdose, overdose, or delayed therapy causing serious harm or death.
Fresenius KabiMar 7, 2024 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump LVP-0004
Fresenius Kabi recalls Ivenix Infusion System Large Volume Pump LVP-0004 due to mechanical interference causing pump alarms and potential therapy delays or interruptions that could lead to serious harm or death.
Fresenius KabiNov 29, 2023 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004
Fresenius Kabi recalls Ivenix Infusion System software version 5.2.1/5.2.2 due to potential incorrect alarms that may delay therapy or cause over-infusion. Affected units were corrected in software version 5.8.0 by May-August 2023.
Fresenius KabiMay 10, 2023 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump, Model No. LVP-0004
Recall of Fresenius Kabi Ivenix Infusion System Large Volume Pump Model LVP-0004 due to fluid ingress causing electrical failure and infusion halt. Affected units have specific serial numbers listed in the recall notice.
Fresenius KabiMar 10, 2023 - Lower riskDrug
Fresenius Kabi USA, LLC recalls Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.5%, 250 mg
Fresenius Kabi recalls Sensorcaine injections with subpotent epinephrine due to testing below defined limits. Affected batches expire April 2024. Stop using immediately if you have the recalled product.
Fresenius KabiNov 22, 2022 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls LVP software of the Ivenix Infusion System (IIS), LVP-SW-0004
Fresenius Kabi recalls Ivenix Infusion System software versions 5.0.1 and earlier due to potential incorrect alarms causing therapy delays or harm. Affected users should check their software version.
Fresenius KabiSep 16, 2022 - Use cautionMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0
Fresenius Kabi recalls Ivenix Infusion System software version 5.2.0 due to potential screen freezing that can interrupt medication flow. Affected users should contact the company for updates.
Fresenius KabiSep 8, 2022 - Lower riskMedical device
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump (LVP) Software: 5.0.0 and 5.0.1 Part Number: LVP-SW-0004. Indicated for
Fresenius Kabi recalls Ivenix Infusion System software versions 5.0.0 and 5.0.1 due to potential flow rate timing issues that could exceed 6 minutes in certain conditions. Affected units have specific software and part numbers.
Fresenius KabiApr 22, 2022 - Stop using nowDrug
Fresenius Kabi USA, LLC recalls Sodium Acetate Injection, USP, 400 mEq / 100 mL (4 mEq / mL), packaged in 2 trays of 20 vials per shipper (NDC
Fresenius Kabi recalls Sodium Acetate Injection with particulate matter that could cause serious injury. Affected lots expire through 2023. Contact for return instructions.
Fresenius KabiMar 4, 2022 - Stop using nowDrug
Fresenius Kabi USA LLC recalls Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047,
Fresenius Kabi recalls Morphine Sulfate Injection vials with cracked containers that may cause contamination. Affected lots expire 03/2023 or 06/2023. Stop using and contact for replacement.
Fresenius KabiSep 17, 2021 - Lower riskDrug
Fresenius Kabi USA LLC recalls Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL),
Fresenius Kabi recalls Xylocaine-MPF with Epinephrine 1:200,000 injection due to low epinephrine assay results. This may affect medical use safety. Check vial NDC 63323-487-07 or tray NDC 63323-487-37 for affected units.
Fresen:ius KabiJun 25, 2021 - Use cautionDrug
Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL
Fresenius Kabi recalls Ketorolac injection vials due to particulate matter found in some samples. This may cause serious injury if injected. Check your vial's lot number and contact the company for details.
Fresenius KabiDec 23, 2020 - Use cautionDrug
Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only,
Fresenius Kabi recalls Ketorol: 60mg/2mL injection vials due to particulate matter found in reserve samples. This may cause serious injury if injected.
Fresen: KabiDec 17, 2020 - Lower riskDrug
Fresenius Kabi USA, LLC recalls Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single
Fresenius Kabi recalls Sensorcaine-MPF injections with low epinephrine levels that may cause ineffective anesthesia. Patients should contact their doctor for alternatives.
Fresenius KabiDec 10, 2020 - Lower riskDrug
Fresenius Kabi USA, LLC recalls Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only,
Fresenius Kabi recalls specific dexmedetomidine injection due to trace lidocaine contamination. Patients using this medication may face unintended effects from cross-contamination.
Fresenius KabiNov 17, 2020 - Lower riskDrug
Fresenius Kabi USA, LLC recalls DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx
Fresenius Kabi recalls DOXOrubicin Hydrochloride Injection due to trace octreotide contamination. This may cause cross-contamination with other products. Affected units have NDC 63323-883-05, batch 6120525.
Fresenius KabiNov 17, 2020 - Lower riskDrug
Fresenius Kabi USA, LLC recalls Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion,
Fresenius Kabi recalls specific dexmedetomidine injection lots due to trace lidocaine cross contamination. This may cause adverse reactions in patients receiving IV infusions.
Fresenius KabiJul 22, 2020 - Lower riskDrug
Fresenius Kabi USA, LLC recalls Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047;
Fresenius Kabi recalls Fosaprepitant injection vials with incorrect EDTA labeling. This labeling error may affect medication accuracy. Affected vials have specific NDC and lot numbers. Contact for details.
Fresenius KabiJul 13, 2020 - Stop using nowDrug
Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL
Fresenius Kabi recalls over 5 million vials of Ketorolac Tromethamine Injection due to particulate matter. Check lot numbers and expiration dates for affected units.
Fresenius KabiApr 20, 2020 - Use cautionDrug
Fresenius Kabi USA, LLC recalls Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi,
Fresenius Kabi recalls Fluorouracil Injection vials with glass particulates that could cause serious injury during medical use. Affected lots include NDC 63323-117-61 and 63323-117-69.
Fresenius KabiJun 28, 2019 - UnratedDrug
Fresenius Kabi USA, LLC recalls Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047, NDC
Fresenius Kabi recalls 40mg/20mL ondansetron injection vials due to failed impurities and degradation specifications. This may pose a risk of harmful substances in the medication.
Fresenius KabiMay 22, 2019 - Lower riskDrug
Fresenius Kabi USA, LLC recalls SODIUM CHLORIDE INJECTION, USP, 0.9%, 20 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only, APP Pharmaceuticals,
Fresenius Kabi recalls 0.9% sodium chloride injection vials with natural rubber latex in stoppers. Incorrect labeling may cause allergic reactions in sensitive users. Check product codes and lots for affected items.
Fresenius KabiNov 15, 2018 - UnratedDrug
Fresenius Kabi USA, LLC recalls Vecuronium bromide for Injection, 10 mg vials, Rx only, Mfd. for: Fresenius Kabi, Lake Zurich, IL 60047, Made in India,
Fresenius Kabi recalls 10mg Vecuronium bromide vials (NDC 63323-781-10, Lot ZG603) due to impurities detected in stability testing. This medication is for injection only and requires immediate action.
Fresenius KabiJan 16, 2018 - Use cautionDrug
Fresenius Kabi USA, LLC recalls Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per
Fresenius Kabi recalls 24-pack midazolam injection syringes that are mislabeled with ondansetron instead. This mix-up could lead to incorrect medication use. Consumers should check their syringes and contact the company for details.
Fresenius KabiOct 27, 2017 - Lower riskDrug
Fresenius Kabi USA, LLC recalls Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC
Fresenius Kabi recalls Fluphenazine Decanoate Injection vials with subpotent drug levels. Affected lots expire by July 2017. Contact for remedy details.
Fresenius KabiMar 16, 2017 - Use cautionDrug
Fresenius Kabi USA, LLC recalls MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC
Fresenius Kabi USA recalls specific lots of Midazolam Injection USP due to failed impurity specifications. Check lot numbers and expiration dates.
Fresenius KabiDec 16, 2016 - UnratedDrug
Fresenius Kabi USA, LLC recalls OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius
Fresenius Kabi USA recalls specific lots of Octreotide Acetate Injection due to failed impurity specifications. Check your vial lot numbers and expiration dates.
Fresenius KabiMay 4, 2016 - Stop using nowDrug
Fresenius Kabi USA, LLC recalls Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC,
Fresenius Kabi USA recalls Sensorcaine-MPF (Bupivacaine HCl) 0.75% vials due to glass particulate matter. Check lot #6111504.
Fresenius KabiApr 25, 2016 - UnratedDrug
Fresenius Kabi USA, LLC recalls Haloperidol Decanoate Injection, 50 mg/mL, 1 mL vial, Rx Only. Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC
Fresenius Kabi USA recalls one lot of Haloperidol Decanoate Injection due to failed impurity specifications. Check your vial details.
Fresenius KabiApr 7, 2016 - Use cautionDrug
Fresenius Kabi USA, LLC recalls Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dose Vial,
Fresenius Kabi USA recalls 94,560 vials of Cisatracurium Besylate Injection due to incorrect labeling regarding preservative content.
Fresenius KabiApr 5, 2016 - Use cautionDrug
Fresenius Kabi USA, LLC recalls Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Fresenius
Fresenius Kabi USA recalls 93,000 vials of Hydralazine Hydrochloride Injection due to an incorrect expiration date printed on the secondary packaging.
Fresenius KabiJul 28, 2015 - Use cautionDrug
Fresenius Kabi USA, LLC recalls Rifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 Corporate Drive,
Fresenius Kabi USA recalls specific lots of Rifampin for Injection due to failed impurity and degradation specifications. Check your vial details.
Fresenius KabiJun 4, 2015 - Use cautionDrug
Fresenius Kabi USA, LLC recalls KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free],
Fresenius Kabi recalls KABIVEN injectable emulsion bags due to a labeling error where amino acid strength is incorrectly declared. Check lot numbers and expiry dates.
Fresenius KabiApr 28, 2015 - Stop using nowDrug
Fresenius Kabi USA, LLC recalls GENTAMICIN INJECTION, USP, equivalent to 40 mg/mL, Rx only, 20 mL Multiple Dose Vial, Manufactured by APP
Fresenius Kabi USA recalls 92,125 vials of Gentamicin Injection (NDC 63323-010-20) because stoppers may be missing from the containers.
Fresenius KabiNov 12, 2014 - Use cautionDrug
Fresenius Kabi USA, LLC recalls PROPRANOLOL HYDROCHLORIDE INJECTION, USP 1 mg/mL, 1 mL Single Dose Vial, Rx only, APP Pharmaceuticals, LLC Schaumburg,
Fresenius Kabi USA, LLC recalls specific lots of Propranolol Hydrochloride Injection due to CGMP deviations at the API supplier. Check your vial details.
Fresenius KabiAug 13, 2014 - Stop using nowDrug
Fresenius Kabi USA, LLC recalls Fosphenytoin Sodium Injection, USP, 100 mg PE/2 mL (50 mg PE/mL) (PE= phenytoin sodium equivalents) 2 mL Single Use
Fresenius Kabi USA recalls over 2 million vials of Fosphenytoin Sodium Injection due to potential glass particulates. Check lot numbers and consult a healthcare provider.
Fresenius KabiMay 2, 2014 - UnratedDrug
Fresenius Kabi USA LLC recalls HALOPERIDOL DECANOATE INJECTION, 50 mg/mL, 1 mL vial, Rx only, Fresenius Kabi USA, LLC, Schaumburg, IL 60173 NDC
Fresenius Kabi USA LLC is recalling three lots of Haloperidol Decanoate Injection due to failed impurity specifications. Check lot numbers if you have this Rx drug.
Fresenius KabiApr 14, 2014 - Use cautionDrug
Fresenius Kabi USA, LLC recalls Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx
Fresenius Kabi USA recalls specific lots of Heparin Sodium Injection because the drug may be subpotent, posing a risk of ineffective treatment.
Fresenius KabiJan 22, 2014 - Use cautionDrug
Fresenius Kabi USA, LLC recalls FOLIC ACID INJECTION, USP; 5 mg/mL ; For IM, IV or SC Use; 10 mL; Multiple Dose Vial; Rx only; APP Pharmaceuticals,
APP Pharmaceuticals recalls specific lots of Folic Acid Injection due to failed impurity specifications. Check your vial lot numbers and expiration dates immediately.
APP PharmaceuticalsDec 6, 2013 - Use cautionDrug
Fresenius Kabi USA, LLC recalls PACLITAXEL INJECTION, USP (semisynthetic); 300 mg/50 mL; (6 mg/mL); Multiple Dose Vial;(NDC 63323-763-50); Rx Only;
Fresenius Kabi recalls specific lots of Paclitaxel Injection due to missing text in the Clinical Studies and Specific Adverse Events sections of the package insert.
Fresenius KabiNov 8, 2013
Fresenius Kabi USA, LLC recall questions
How many recalls has Fresenius Kabi USA, LLC had?
94 recalls from Fresenius Kabi USA, LLC are on record with U.S. safety agencies, from 2012–2026 (70 drug, 24 medical device).
What is the most recent Fresenius Kabi USA, LLC recall?
Fresenius Kabi USA, LLC recalls Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA,, dated Aug 10, 2026. Every Fresenius Kabi USA, LLC recall is listed on this page, newest first.
Why are Fresenius Kabi USA, LLC products recalled?
The most common reasons on record: Lack of Assurance of Sterility (14); Potential for external cassette leaks (4); Presence of Particulate Matter - found in reserve sample vials at the firm. (4); Presence of Particulate Matter: Hair was found in products (4).
What should I do if I have a recalled Fresenius Kabi USA, LLC product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Fresenius Kabi USA, LLC recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.